Ginkgo Bioworks (NYSE: DNA, "Ginkgo") and Invaio Sciences, an agricultural biotechnology company leading in nature-positive ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.00 in the latest trading session, marking a -3.12% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.1%. On the ...

Ginkgo Bioworks has snared one of its biggest partners to date. The biology biotech will work with none other than Pfizer in a drug discovery deal for RNA medicines worth $331 million in biobucks for ...

This year's AGM marked a meaningful milestone: 15 years of disciplined growth, consistent risk management and capital preservation - principles that have enabled Ginkgo MIC to navigate multiple ...

Remedies designed for the infirm seldom aid the healthy, too. Donning bifocals won’t turn 20/20 eyesight into X-ray vision, and wearing a hearing aid can’t endow a nonmusician with the gift of perfect ...

Behzad Mahdavi, Senior Vice President Biopharma Manufacturing & Life Sciences Tools at Ginkgo Bioworks. Cell and gene therapies may be the most anticipated invention of this century. For many people, ...

A major Cochrane review examines whether a widely used herbal supplement truly supports cognitive function, revealing modest dementia benefits but limited evidence for prevention or early impairment.

I’ve been following your articles for years. I was most recently interested in your opinion (9/8/02) regarding the ginkgo study which stated that ginkgo was “ineffective.” Your clear and concise ...